US Stock MarketDetailed Quotes

The Oncology Institute (TOI)

Watchlist
  • 3.380
  • +0.080+2.42%
Close Apr 14 16:00 ET
  • 3.380
  • 0.0000.00%
Post 20:01 ET
334.08MMarket Cap-6.26P/E (TTM)

The Oncology Institute (TOI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
7.35%-24.59M
-22.77%3.23M
-1,642.12%-12.63M
34.85%-10.2M
68.60%-4.99M
26.92%-26.54M
207.53%4.19M
109.86%819K
-80.83%-15.66M
-2.79%-15.88M
Net income from continuing operations
6.27%-60.61M
43.04%-7.51M
-2.43%-16.5M
-9.88%-17.01M
1.53%-19.59M
22.16%-64.66M
29.71%-13.18M
7.50%-16.11M
8.39%-15.48M
33.70%-19.89M
Operating gains losses
587.72%14.85M
-2,522.73%-1.07M
1,189.84%6.22M
350.67%6.34M
27,833.33%3.35M
-389.55%-3.05M
-96.98%44K
-128.62%-571K
-311.38%-2.53M
100.35%12K
Depreciation and amortization
10.45%6.94M
-4.39%1.63M
9.54%1.72M
18.91%1.81M
19.81%1.78M
7.05%6.29M
8.24%1.71M
-7.36%1.57M
14.22%1.52M
17.34%1.49M
Deferred tax
---32K
--0
--0
----
----
--0
--0
--0
--0
--0
Other non cash items
32.91%8.38M
-24.40%1.21M
-49.70%1.08M
20.93%1.23M
212.64%4.87M
16.72%6.31M
2.11%1.59M
106.67%2.14M
-50.22%1.01M
102.20%1.56M
Change In working capital
-92.66%1.33M
-39.90%7.65M
-153.84%-6.17M
3.55%-3.29M
214.53%3.13M
665.54%18.06M
97.55%12.73M
1,131.77%11.46M
-289.12%-3.41M
42.81%-2.73M
-Change in receivables
-118.06%-12.58M
-89.35%658K
-720.08%-4.04M
-272.48%-8.21M
93.93%-985K
-28.28%-5.77M
54.24%6.18M
75.90%-493K
1,040.91%4.76M
-172.46%-16.22M
-Change in inventory
-287.85%-6.84M
2,895.52%2.01M
-354.61%-3.1M
-1,599.14%-3.48M
-206.83%-2.27M
182.99%3.64M
104.55%67K
20,366.67%1.22M
112.12%232K
313.90%2.12M
-Change in prepaid assets
72.87%2.03M
-80.57%230K
453.00%553K
346.83%2.33M
-71.38%-1.08M
-62.40%1.18M
196.00%1.18M
-93.89%100K
-53.27%521K
-2,520.83%-629K
-Change in payables and accrued expense
2.70%19.19M
-9.69%4.87M
-94.57%566K
169.24%6.13M
-34.98%7.62M
129.02%18.69M
49.07%5.4M
1,953.56%10.42M
-365.56%-8.85M
562.80%11.73M
-Change in other current assets
39.29%-17K
-1,900.00%-20K
--0
18.39%-1.44M
-17.24%1.45M
-100.49%-28K
-100.07%-1K
-100.45%-6K
-204.25%-1.77M
29.33%1.75M
-Change in other current liabilities
94.58%-11K
8,300.00%84K
128.98%122K
-18.08%1.39M
-8.58%-1.61M
96.48%-203K
100.07%1K
71.05%-421K
188.35%1.7M
-59.76%-1.48M
-Change in other working capital
-180.86%-452K
-95.60%-178K
----
----
----
--559K
---91K
----
----
----
Cash from discontinued investing activities
Operating cash flow
7.35%-24.59M
-22.77%3.23M
-1,642.12%-12.63M
34.85%-10.2M
68.60%-4.99M
26.92%-26.54M
207.53%4.19M
109.86%819K
-80.83%-15.66M
-2.79%-15.88M
Investing cash flow
Cash flow from continuing investing activities
-106.65%-3.07M
39.60%-1.06M
-105.81%-604K
-106.65%-1.21M
-101.04%-202K
-26.23%46.21M
-115.09%-1.76M
34.93%10.4M
-27.01%18.18M
5.36%19.39M
Net PPE purchase and sale
15.54%-3.2M
39.60%-1.06M
-250.25%-604K
33.84%-1.21M
46.23%-328K
17.04%-3.79M
-103.83%-1.76M
143.23%402K
-94.88%-1.83M
66.83%-610K
Net business purchase and sale
----
----
----
----
----
--0
--0
--0
----
----
Net investment purchase and sale
--0
--0
--0
--0
--0
-30.23%50M
--0
15.75%10M
-33.64%20M
-1.20%20M
Net other investing changes
--126K
--0
--0
--0
--126K
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-106.65%-3.07M
39.60%-1.06M
-105.81%-604K
-106.65%-1.21M
-101.04%-202K
-26.23%46.21M
-115.09%-1.76M
34.93%10.4M
-27.01%18.18M
5.36%19.39M
Financing cash flow
Cash flow from continuing financing activities
430.96%11.56M
2,376.83%3.73M
4,462.14%10.6M
191.43%1.96M
-405.33%-4.74M
49.00%-3.49M
90.79%-164K
67.86%-243K
17.45%-2.15M
45.11%-938K
Net issuance payments of debt
-51,276.92%-20.04M
10.00%-9K
27.27%-8K
-11.11%-10K
-222,233.33%-20.01M
61.39%-39K
0.00%-10K
-10.00%-11K
85.71%-9K
50.00%-9K
Net common stock issuance
--29.2M
--3.89M
--9.95M
--0
--15.36M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
4,480.00%3.44M
--204K
--891K
110,050.00%2.2M
87.67%137K
-40.48%75K
--0
--0
--2K
--73K
Net other financing activities
70.49%-1.04M
-127.27%-350K
-1.29%-235K
89.25%-230K
77.45%-226K
39.72%-3.53M
91.83%-154K
63.41%-232K
-30.17%-2.14M
40.75%-1M
Cash from discontinued financing activities
Financing cash flow
430.96%11.56M
2,376.83%3.73M
4,462.14%10.6M
191.43%1.96M
-405.33%-4.74M
49.00%-3.49M
90.79%-164K
67.86%-243K
17.45%-2.15M
45.11%-938K
Net cash flow
Beginning cash position
48.32%49.67M
-41.65%27.66M
-16.84%30.29M
10.22%39.74M
48.32%49.67M
139.03%33.49M
72.15%47.4M
26.07%36.42M
136.43%36.06M
139.03%33.49M
Current changes in cash
-199.52%-16.1M
160.56%5.91M
-123.99%-2.63M
-2,660.16%-9.45M
-486.83%-9.93M
-16.93%16.18M
-61.92%2.27M
908.99%10.98M
-97.30%369K
107.02%2.57M
End cash Position
-32.42%33.57M
-32.42%33.57M
-41.65%27.66M
-16.84%30.29M
10.22%39.74M
48.32%49.67M
48.32%49.67M
72.15%47.4M
26.07%36.42M
136.43%36.06M
Free cash flow
8.38%-27.79M
-10.61%2.17M
-1,183.87%-13.23M
34.75%-11.41M
67.77%-5.32M
25.82%-30.33M
151.14%2.43M
113.21%1.22M
-82.20%-17.49M
4.62%-16.49M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 7.35%-24.59M-22.77%3.23M-1,642.12%-12.63M34.85%-10.2M68.60%-4.99M26.92%-26.54M207.53%4.19M109.86%819K-80.83%-15.66M-2.79%-15.88M
Net income from continuing operations 6.27%-60.61M43.04%-7.51M-2.43%-16.5M-9.88%-17.01M1.53%-19.59M22.16%-64.66M29.71%-13.18M7.50%-16.11M8.39%-15.48M33.70%-19.89M
Operating gains losses 587.72%14.85M-2,522.73%-1.07M1,189.84%6.22M350.67%6.34M27,833.33%3.35M-389.55%-3.05M-96.98%44K-128.62%-571K-311.38%-2.53M100.35%12K
Depreciation and amortization 10.45%6.94M-4.39%1.63M9.54%1.72M18.91%1.81M19.81%1.78M7.05%6.29M8.24%1.71M-7.36%1.57M14.22%1.52M17.34%1.49M
Deferred tax ---32K--0--0----------0--0--0--0--0
Other non cash items 32.91%8.38M-24.40%1.21M-49.70%1.08M20.93%1.23M212.64%4.87M16.72%6.31M2.11%1.59M106.67%2.14M-50.22%1.01M102.20%1.56M
Change In working capital -92.66%1.33M-39.90%7.65M-153.84%-6.17M3.55%-3.29M214.53%3.13M665.54%18.06M97.55%12.73M1,131.77%11.46M-289.12%-3.41M42.81%-2.73M
-Change in receivables -118.06%-12.58M-89.35%658K-720.08%-4.04M-272.48%-8.21M93.93%-985K-28.28%-5.77M54.24%6.18M75.90%-493K1,040.91%4.76M-172.46%-16.22M
-Change in inventory -287.85%-6.84M2,895.52%2.01M-354.61%-3.1M-1,599.14%-3.48M-206.83%-2.27M182.99%3.64M104.55%67K20,366.67%1.22M112.12%232K313.90%2.12M
-Change in prepaid assets 72.87%2.03M-80.57%230K453.00%553K346.83%2.33M-71.38%-1.08M-62.40%1.18M196.00%1.18M-93.89%100K-53.27%521K-2,520.83%-629K
-Change in payables and accrued expense 2.70%19.19M-9.69%4.87M-94.57%566K169.24%6.13M-34.98%7.62M129.02%18.69M49.07%5.4M1,953.56%10.42M-365.56%-8.85M562.80%11.73M
-Change in other current assets 39.29%-17K-1,900.00%-20K--018.39%-1.44M-17.24%1.45M-100.49%-28K-100.07%-1K-100.45%-6K-204.25%-1.77M29.33%1.75M
-Change in other current liabilities 94.58%-11K8,300.00%84K128.98%122K-18.08%1.39M-8.58%-1.61M96.48%-203K100.07%1K71.05%-421K188.35%1.7M-59.76%-1.48M
-Change in other working capital -180.86%-452K-95.60%-178K--------------559K---91K------------
Cash from discontinued investing activities
Operating cash flow 7.35%-24.59M-22.77%3.23M-1,642.12%-12.63M34.85%-10.2M68.60%-4.99M26.92%-26.54M207.53%4.19M109.86%819K-80.83%-15.66M-2.79%-15.88M
Investing cash flow
Cash flow from continuing investing activities -106.65%-3.07M39.60%-1.06M-105.81%-604K-106.65%-1.21M-101.04%-202K-26.23%46.21M-115.09%-1.76M34.93%10.4M-27.01%18.18M5.36%19.39M
Net PPE purchase and sale 15.54%-3.2M39.60%-1.06M-250.25%-604K33.84%-1.21M46.23%-328K17.04%-3.79M-103.83%-1.76M143.23%402K-94.88%-1.83M66.83%-610K
Net business purchase and sale ----------------------0--0--0--------
Net investment purchase and sale --0--0--0--0--0-30.23%50M--015.75%10M-33.64%20M-1.20%20M
Net other investing changes --126K--0--0--0--126K--------------------
Cash from discontinued investing activities
Investing cash flow -106.65%-3.07M39.60%-1.06M-105.81%-604K-106.65%-1.21M-101.04%-202K-26.23%46.21M-115.09%-1.76M34.93%10.4M-27.01%18.18M5.36%19.39M
Financing cash flow
Cash flow from continuing financing activities 430.96%11.56M2,376.83%3.73M4,462.14%10.6M191.43%1.96M-405.33%-4.74M49.00%-3.49M90.79%-164K67.86%-243K17.45%-2.15M45.11%-938K
Net issuance payments of debt -51,276.92%-20.04M10.00%-9K27.27%-8K-11.11%-10K-222,233.33%-20.01M61.39%-39K0.00%-10K-10.00%-11K85.71%-9K50.00%-9K
Net common stock issuance --29.2M--3.89M--9.95M--0--15.36M--0--0--0--0--0
Proceeds from stock option exercised by employees 4,480.00%3.44M--204K--891K110,050.00%2.2M87.67%137K-40.48%75K--0--0--2K--73K
Net other financing activities 70.49%-1.04M-127.27%-350K-1.29%-235K89.25%-230K77.45%-226K39.72%-3.53M91.83%-154K63.41%-232K-30.17%-2.14M40.75%-1M
Cash from discontinued financing activities
Financing cash flow 430.96%11.56M2,376.83%3.73M4,462.14%10.6M191.43%1.96M-405.33%-4.74M49.00%-3.49M90.79%-164K67.86%-243K17.45%-2.15M45.11%-938K
Net cash flow
Beginning cash position 48.32%49.67M-41.65%27.66M-16.84%30.29M10.22%39.74M48.32%49.67M139.03%33.49M72.15%47.4M26.07%36.42M136.43%36.06M139.03%33.49M
Current changes in cash -199.52%-16.1M160.56%5.91M-123.99%-2.63M-2,660.16%-9.45M-486.83%-9.93M-16.93%16.18M-61.92%2.27M908.99%10.98M-97.30%369K107.02%2.57M
End cash Position -32.42%33.57M-32.42%33.57M-41.65%27.66M-16.84%30.29M10.22%39.74M48.32%49.67M48.32%49.67M72.15%47.4M26.07%36.42M136.43%36.06M
Free cash flow 8.38%-27.79M-10.61%2.17M-1,183.87%-13.23M34.75%-11.41M67.77%-5.32M25.82%-30.33M151.14%2.43M113.21%1.22M-82.20%-17.49M4.62%-16.49M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More